» Articles » PMID: 31614169

Preparation of Virus-like Particle Mimetic Nanovesicles Displaying the S Protein of Middle East Respiratory Syndrome Coronavirus Using Insect Cells

Overview
Journal J Biotechnol
Date 2019 Oct 16
PMID 31614169
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) first emerged in 2012, and over 2000 infections and 800 deaths have been confirmed in 27 countries. However, to date, no commercial vaccine is available. In this study, structural proteins of MERS-CoV were expressed in silkworm larvae and Bm5 cells for the development of vaccine candidates against MERS-CoV and diagnostic methods. The spike (S) protein of MERS-CoV lacking its transmembrane and cytoplasmic domains (SΔTM) was secreted into the hemolymph of silkworm larvae using a bombyxin signal peptide and purified using affinity chromatography. The purified SΔTM forms small nanoparticles as well as the full-length S protein and has the ability to bind human dipeptidyl peptidase 4 (DPP4), which is a receptor of MERS-CoV. These results indicate that bioactive SΔTM was expressed in silkworm larvae. To produce MERS-CoV-like particles (MERS-CoV-LPs), the coexpression of spike proteins was performed in Bm5 cells and envelope (E) and membrane (M) proteins secreted E and M proteins extracellularly, suggesting that MERS-CoV-LPs may be formed. However, this S protein was not displayed on virus-like particles (VLPs) even though E and M proteins were secreted into the culture supernatant. By surfactant treatment and mechanical extrusion using S protein- or three structural protein-expressing Bm5 cells, S protein-displaying nanovesicles with diameters of approximately 100-200 nm were prepared and confirmed by immuno-TEM. The mechanical extrusion method is favorable for obtaining uniform recombinant protein-displaying nanovesicles from cultured cells. The purified SΔTM from silkworm larvae and S protein-displaying nanovesicles from Bm5 cells may lead to the development of nanoparticle-based vaccines against MERS-CoV and the diagnostic detection of MERS-CoV.

Citing Articles

Prophylactic and therapeutic vaccine development: advancements and challenges.

Weerarathna I, Doelakeh E, Kiwanuka L, Kumar P, Arora S Mol Biomed. 2024; 5(1):57.

PMID: 39527305 PMC: 11554974. DOI: 10.1186/s43556-024-00222-x.


An Overview of Recent Developments in the Application of Antigen Displaying Vaccine Platforms: Hints for Future SARS-CoV-2 VLP Vaccines.

Utomo D, Suhaimi H, Azami N, Azmi F, Amin M, Xu J Vaccines (Basel). 2023; 11(9).

PMID: 37766182 PMC: 10536610. DOI: 10.3390/vaccines11091506.


Functional Nanomaterials Enhancing Electrochemical Biosensors as Smart Tools for Detecting Infectious Viral Diseases.

Curulli A Molecules. 2023; 28(9).

PMID: 37175186 PMC: 10180161. DOI: 10.3390/molecules28093777.


A perspective on SARS-CoV-2 virus-like particles vaccines.

Gao X, Xia Y, Liu X, Xu Y, Lu P, Dong Z Int Immunopharmacol. 2023; 115:109650.

PMID: 36649673 PMC: 9832101. DOI: 10.1016/j.intimp.2022.109650.


Vaccine development for zoonotic viral diseases caused by positive‑sense single‑stranded RNA viruses belonging to the and families (Review).

Babaeimarzangou S, Zaker H, Soleimannezhadbari E, Gamchi N, Kazeminia M, Tarighi S Exp Ther Med. 2022; 25(1):42.

PMID: 36569444 PMC: 9768462. DOI: 10.3892/etm.2022.11741.


References
1.
Ma C, Li Y, Wang L, Zhao G, Tao X, Tseng C . Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines. Vaccine. 2014; 32(18):2100-8. PMC: 4194189. DOI: 10.1016/j.vaccine.2014.02.004. View

2.
. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill. 2013; 18(11):20427. DOI: 10.2807/ese.18.11.20427-en. View

3.
Gibson D . Enzymatic assembly of overlapping DNA fragments. Methods Enzymol. 2011; 498:349-61. PMC: 7149801. DOI: 10.1016/B978-0-12-385120-8.00015-2. View

4.
McBride C, Li J, Machamer C . The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein. J Virol. 2006; 81(5):2418-28. PMC: 1865919. DOI: 10.1128/JVI.02146-06. View

5.
Ma C, Wang L, Tao X, Zhang N, Yang Y, Tseng C . Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design. Vaccine. 2014; 32(46):6170-6176. PMC: 4194190. DOI: 10.1016/j.vaccine.2014.08.086. View